Completed

REVADEThis is a Non-randomized, Single-center, Prospective Investigation on Exercise Capacities of Left Ventricular Assist Devices Recipients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

adding 2 cardiopulmonary exercise testings : peak oxygen consumption (VO2 max) and stress echocardiography

Other
Who is being recruted

Behavior

+ Motor Activity

Over 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Interventional
Study Start: February 2014
See protocol details

Summary

Principal SponsorRennes University Hospital
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2014

Actual date on which the first participant was enrolled.

This is a non-randomized, single-center, prospective investigation on exercise capacities of LVAD recipients. LVAD patients already have in our unit the following regular monitoring: * clinical examination * Minnesota Living with Heart Failure Questionnaire (MLHFQ) * SF-36 Health Survey * Six-Minute Walk Test * resting echocardiography * routine blood tests. The REVADE pilot study consists in adding 2 cardiopulmonary exercise testings to their existing follow-up : peak oxygen consumption (VO2 max) and stress echocardiography. We plan to do 1 stress echocardiography on a supine bicycle over the follow-up, and 1 peak oxygen consumption recorded while breathing through a gas analyzer. Total study length of time will be 1 year. Expected number of enrolled patients is 18.

Official TitleThis is a Non-randomized, Single-center, Prospective Investigation on Exercise Capacities of Left Ventricular Assist Devices Recipients
NCT02067455
Principal SponsorRennes University Hospital
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

12 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorMotor Activity

Criteria

3 inclusion criteria required to participate
left ventricular assist device (LVAD) recipients
age > 18 years
able to give consent
3 exclusion criteria prevent from participating
adults legally protected (under judicial protection, guardianship, or supervision) or deprived of liberty
patients unable to provide sufficient effort for exercise testing
poor echogenicity

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Service de cardiologie - Rennes university hospital

Rennes, FranceOpen Service de cardiologie - Rennes university hospital in Google Maps
CompletedOne Study Center